Articles

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning

Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Institute of Software and Multimedia Technology, Technical University Dresden, Dresden
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich
Medical Clinic III, Hospital Leverkusen, Leverkusen
Hospital Barmherzige Brueder Regensburg, Regensburg
Institute for Biometrics and Clinical Research, University Muenster, Muenster
Institute for Biometrics and Clinical Research, University Muenster, Muenster
Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich
Department of Internal Medicine A, University Hospital Muenster, Muenster
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig
Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg
Department of Medicine V, University Hospital Heidelberg, Heidelberg
Department of Medicine 2, Hematology and Oncology, Goethe University Frankfurt, Frankfurt
Department of Hematology and Oncology, University Hospital Schleswig Holstein, Kiel
Department of Internal Medicine 5, Paracelsus Medical Private University Nuremberg, Nuremberg
Department of Hematology, Oncology and Palliative Care, Robert-Bosch Hospital, Stuttgart
Department of Internal Medicine 5, University Hospital Erlangen, Erlangen
Department of Internal Medicine 3, Klinikum Chemnitz GmbH, Chemnitz, Germany; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen
Department of Internal Medicine A, University Hospital Muenster, Muenster
Department of Internal Medicine 3, Klinikum Chemnitz GmbH, Chemnitz, Germany; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany; German Consortium for Translational Cancer Research DKFZ, Heidelberg, Germany; National Center for Tumor Diseases (NCT), Dresden
Medical Clinic and Policlinic I Hematology and Cell Therapy. University Hospital, Leipzig
Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden
Haematologica Early view Jun 16, 2022 https://doi.org/10.3324/haematol.2021.280027